Unilever’s soap opera: M&A, job cuts, Nelson Peltz joining board

Unilever’s soap opera: M&A, job cuts, Nelson Peltz joining board

Unilever appointed Nelson Peltz to its board on Tuesday as it engaged in talks about strategy with the American activist investor, who now holds a roughly 1.5% stake in the consumer goods giant. The maker of Dove soap and Magnum ice cream has had a bumpy few years, with shares falling about a quarter from … Read more

Canada authorises first plant-based COVID-19 vaccine

Canada authorises first plant-based COVID-19 vaccine

The decision was based on a study of 24,000 adults that found the vaccine was 71% effective at preventing COVID-19 — although that was before the omicron variant emerged. Canada has become the first country to authorize use of a plant-based COVID-19 vaccine. Canadian regulators said Thursday Medicago’s two-dose vaccine can be given to adults … Read more

Unilever eyes GSK’s consumer goods arm in possible 50 billion-pound deal

Unilever eyes GSK’s consumer goods arm in possible 50 billion-pound deal

Consumer goods giant said it had approached about buying the pharmaceutical group’s consumer goods arm, after a newspaper reported that a 50 billion-pound ($68.4 billion) bid it made had been rebuffed. Unilever, which has been under fire from some investors for the group’s underperforming share price, confirmed the approach about a potential acquisition of the … Read more

Developing Countries Push to Limit Patent Protections for Covid-19 Vaccines

Developing Countries Push to Limit Patent Protections for Covid-19 Vaccines

A group of developing countries, backed by United Nations agencies and activist groups, is pushing to limit patent protections for Covid-19 vaccines being tested by some of the world’s biggest pharmaceutical companies so that inexpensive copies can be produced for poorer nations. South Africa, Ghana, Senegal, Pakistan and others argue they won’t be able to … Read more